CN Patent

CN102438452B — 包含cdk抑制剂的化合物和组合物以及用于癌症治疗的方法

Assigned to Shandong University · Expires 2015-02-25 · 11y expired

What this patent protects

本文公开的是适合用作抗肿瘤剂的化合物、用于治疗癌症的方法(其中公开的化合物被用于制备治疗癌症的药物)、治疗肿瘤的方法(其包括给予受试者包含一种或多种公开的细胞毒性剂的组合物)和用于制备公开的抗肿瘤剂的方法。

USPTO Abstract

本文公开的是适合用作抗肿瘤剂的化合物、用于治疗癌症的方法(其中公开的化合物被用于制备治疗癌症的药物)、治疗肿瘤的方法(其包括给予受试者包含一种或多种公开的细胞毒性剂的组合物)和用于制备公开的抗肿瘤剂的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN102438452B
Jurisdiction
CN
Classification
—
Expires
2015-02-25
Drug substance claim
No
Drug product claim
No
Assignee
Shandong University
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.